Navigation Links
Meningitis vaccine study gets £200,000 boost
Date:2/7/2008

meningococci.

Meningitis UK launched its Search 4 a Vaccine Campaign in 2007 to help raise 7million over the next seven years to fund vital work into developing a vaccine against Group B. This innovative project is just one of the studies the charity is funding.

Meningitis UKs Chief Executive Steve Dayman said: We are extremely pleased to be funding Dr Karl Wooldridge and his team in their work to discover more about the proteins secreted by the Meningitis B bacteria. If this research can go forward to help develop a vaccine, thousands of lives could be saved.

Meningitis can be incredibly hard to detect as many of its symptoms are often similar to more minor ailments such as the common cold or flu, plus there are occasions when people show no, or very few, symptoms. For these reasons, we believe the only way to eradicate meningitis completely is through the development of a preventative vaccine.


'/>"/>

Contact: Karl Wooldridge
karl.wooldridge@nottingham.ac.uk
University of Nottingham
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Schedules Revised for Flu, Meningitis Vaccines
2. New Meningitis Vaccine Works in Infants
3. Steroid Fails to Ease Meningitis in Trials
4. Meningitis Shot Available, Effective Year-Round
5. Tattooing Best Way to Deliver DNA Vaccines
6. Novel molecules developed at UB can boost vaccine potency
7. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
8. Another Study Finds No Link Between MMR Vaccine and Autism
9. New hospital standards needed for pediatric flu vaccines
10. Experimental Vaccine Halts Prostate Cancer in Mice
11. Novel vaccine concept developed by scientists at the Wistar Institute
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Samplify Systems Receives Top Honors From Electronic Products and EDN Magazines 2Health News:Samplify Systems Receives Top Honors From Electronic Products and EDN Magazines 3Health News:Spanish On-Sale: Auerbach International Offers Discounted Rates for Spanish Translations 2Health News:Spanish On-Sale: Auerbach International Offers Discounted Rates for Spanish Translations 3Health News:My1Stop.com Partners with Green Business Alliance to Help Customers Go Green 2Health News:South African policy on adolescents' rights to access condoms is causing confusion 2Health News:AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction 2Health News:AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction 3Health News:AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction 4Health News:AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction 5Health News:AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction 6Health News:Iran Uses AIDS Doctors' Imprisonment as First Test of Obama Administration 2Health News:Iran Uses AIDS Doctors' Imprisonment as First Test of Obama Administration 3
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Bavarian Nordic A S Half Year Interim Report 2009 13729 1Bavarian Nordic A S Half Year Interim Report 2009 13729 2Bavarian Nordic A S Half Year Interim Report 2009 13729 3Bavarian Nordic A S Half Year Interim Report 2009 13729 4Bavarian Nordic A S Half Year Interim Report 2009 13729 5Bavarian Nordic A S Half Year Interim Report 2009 13729 6Bavarian Nordic A S Half Year Interim Report 2009 13729 7Promising Cancer Research Treatment Breakthrough Seeks Funding for Corroboration of Results 55591 1Promising Cancer Research Treatment Breakthrough Seeks Funding for Corroboration of Results 55591 2ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 1ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 2ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 3